PRKN and Parkinson disease: In cell and animal models, USP13 participates in ubiquitination modifications of key targets in Parkinson’s disease, such as tau, α-synuclein and E3 ubiquitin ligase parkin (Liu et al., 2019a; Liu et al., 2019b).